The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis

Vinesh Dedhia, Elzbieta Goluszko, Bo Wu, Caishu Deng, Premkumar Christadoss

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

To study the involvement of B cells in the immune response to acetylcholine receptor (AChR), B-cell-deficient (μ mutant) and control wild- type C57BL/6 mice were immunized with AChR and assessed for clinical and immunopathological manifestations of experimental autoimmune myasthenia gravis (EAMG). The μ mutant mice failed to generate anti-AChR antibodies and were completely resistant to the induction of EAMG. However, μ mutant mice developed clinical EAMG when antibodies to the AChR main immunogenic region were passively transferred. Further, the in vivo expansion of lymph node cells after AChR immunization was greatly impaired in μ mutant mice. The μ mutant mice gave an effective in vitro T cell immune response to the immunodominant pathogenic AChR α chain peptide 146-162 (α146-162) and to the whole AChR protein when tested on day 90 after immunization with AChR, whereas the response to both AChR and its α146-162 peptide was reduced when tested on day 7 after immunization. The in vitro production of IFN-γ and IL- 2 by AChR-specific and α146-162 peptide-specific lymphocytes was lower in μ mutant mice. The AChR immune μ mutant T cells proliferated and produced IFN- γ when AChR or α146-162 peptide was presented by wild-type irradiated AChR- primed antigen-presenting cells (APCs). This indicates that B cells are important in the processing and presentation of AChR dominant peptide in vitro during the initial immune response to AChR. However, APCs of non-B- cell lineage are sufficient to process AChR and prime the T cells to AChR dominant T cell epitope peptides.

Original languageEnglish (US)
Pages (from-to)266-275
Number of pages10
JournalClinical Immunology and Immunopathology
Volume87
Issue number3
DOIs
StatePublished - Jun 1998

Fingerprint

Autoimmune Experimental Myasthenia Gravis
Cholinergic Receptors
B-Lymphocytes
Peptides
Immunization
Antigen-Presenting Cells
T-Lymphocytes

Keywords

  • μ gene knockout
  • Antigen presentation
  • B cells
  • Immune response
  • Myasthenia gravis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pathology and Forensic Medicine

Cite this

The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis. / Dedhia, Vinesh; Goluszko, Elzbieta; Wu, Bo; Deng, Caishu; Christadoss, Premkumar.

In: Clinical Immunology and Immunopathology, Vol. 87, No. 3, 06.1998, p. 266-275.

Research output: Contribution to journalArticle

Dedhia, Vinesh ; Goluszko, Elzbieta ; Wu, Bo ; Deng, Caishu ; Christadoss, Premkumar. / The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis. In: Clinical Immunology and Immunopathology. 1998 ; Vol. 87, No. 3. pp. 266-275.
@article{1f41819ccc364f00acbc0494051db30a,
title = "The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis",
abstract = "To study the involvement of B cells in the immune response to acetylcholine receptor (AChR), B-cell-deficient (μ mutant) and control wild- type C57BL/6 mice were immunized with AChR and assessed for clinical and immunopathological manifestations of experimental autoimmune myasthenia gravis (EAMG). The μ mutant mice failed to generate anti-AChR antibodies and were completely resistant to the induction of EAMG. However, μ mutant mice developed clinical EAMG when antibodies to the AChR main immunogenic region were passively transferred. Further, the in vivo expansion of lymph node cells after AChR immunization was greatly impaired in μ mutant mice. The μ mutant mice gave an effective in vitro T cell immune response to the immunodominant pathogenic AChR α chain peptide 146-162 (α146-162) and to the whole AChR protein when tested on day 90 after immunization with AChR, whereas the response to both AChR and its α146-162 peptide was reduced when tested on day 7 after immunization. The in vitro production of IFN-γ and IL- 2 by AChR-specific and α146-162 peptide-specific lymphocytes was lower in μ mutant mice. The AChR immune μ mutant T cells proliferated and produced IFN- γ when AChR or α146-162 peptide was presented by wild-type irradiated AChR- primed antigen-presenting cells (APCs). This indicates that B cells are important in the processing and presentation of AChR dominant peptide in vitro during the initial immune response to AChR. However, APCs of non-B- cell lineage are sufficient to process AChR and prime the T cells to AChR dominant T cell epitope peptides.",
keywords = "μ gene knockout, Antigen presentation, B cells, Immune response, Myasthenia gravis",
author = "Vinesh Dedhia and Elzbieta Goluszko and Bo Wu and Caishu Deng and Premkumar Christadoss",
year = "1998",
month = "6",
doi = "10.1006/clin.1998.4535",
language = "English (US)",
volume = "87",
pages = "266--275",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis

AU - Dedhia, Vinesh

AU - Goluszko, Elzbieta

AU - Wu, Bo

AU - Deng, Caishu

AU - Christadoss, Premkumar

PY - 1998/6

Y1 - 1998/6

N2 - To study the involvement of B cells in the immune response to acetylcholine receptor (AChR), B-cell-deficient (μ mutant) and control wild- type C57BL/6 mice were immunized with AChR and assessed for clinical and immunopathological manifestations of experimental autoimmune myasthenia gravis (EAMG). The μ mutant mice failed to generate anti-AChR antibodies and were completely resistant to the induction of EAMG. However, μ mutant mice developed clinical EAMG when antibodies to the AChR main immunogenic region were passively transferred. Further, the in vivo expansion of lymph node cells after AChR immunization was greatly impaired in μ mutant mice. The μ mutant mice gave an effective in vitro T cell immune response to the immunodominant pathogenic AChR α chain peptide 146-162 (α146-162) and to the whole AChR protein when tested on day 90 after immunization with AChR, whereas the response to both AChR and its α146-162 peptide was reduced when tested on day 7 after immunization. The in vitro production of IFN-γ and IL- 2 by AChR-specific and α146-162 peptide-specific lymphocytes was lower in μ mutant mice. The AChR immune μ mutant T cells proliferated and produced IFN- γ when AChR or α146-162 peptide was presented by wild-type irradiated AChR- primed antigen-presenting cells (APCs). This indicates that B cells are important in the processing and presentation of AChR dominant peptide in vitro during the initial immune response to AChR. However, APCs of non-B- cell lineage are sufficient to process AChR and prime the T cells to AChR dominant T cell epitope peptides.

AB - To study the involvement of B cells in the immune response to acetylcholine receptor (AChR), B-cell-deficient (μ mutant) and control wild- type C57BL/6 mice were immunized with AChR and assessed for clinical and immunopathological manifestations of experimental autoimmune myasthenia gravis (EAMG). The μ mutant mice failed to generate anti-AChR antibodies and were completely resistant to the induction of EAMG. However, μ mutant mice developed clinical EAMG when antibodies to the AChR main immunogenic region were passively transferred. Further, the in vivo expansion of lymph node cells after AChR immunization was greatly impaired in μ mutant mice. The μ mutant mice gave an effective in vitro T cell immune response to the immunodominant pathogenic AChR α chain peptide 146-162 (α146-162) and to the whole AChR protein when tested on day 90 after immunization with AChR, whereas the response to both AChR and its α146-162 peptide was reduced when tested on day 7 after immunization. The in vitro production of IFN-γ and IL- 2 by AChR-specific and α146-162 peptide-specific lymphocytes was lower in μ mutant mice. The AChR immune μ mutant T cells proliferated and produced IFN- γ when AChR or α146-162 peptide was presented by wild-type irradiated AChR- primed antigen-presenting cells (APCs). This indicates that B cells are important in the processing and presentation of AChR dominant peptide in vitro during the initial immune response to AChR. However, APCs of non-B- cell lineage are sufficient to process AChR and prime the T cells to AChR dominant T cell epitope peptides.

KW - μ gene knockout

KW - Antigen presentation

KW - B cells

KW - Immune response

KW - Myasthenia gravis

UR - http://www.scopus.com/inward/record.url?scp=0031783091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031783091&partnerID=8YFLogxK

U2 - 10.1006/clin.1998.4535

DO - 10.1006/clin.1998.4535

M3 - Article

VL - 87

SP - 266

EP - 275

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -